Trial Comparing Multiport RObotic and Laparoscopic Surgery for Elective Colorectal Resections in IBD Patients (ACRO-IBD)
Not applicable · Testing Robotic colorectal surgery and Laparoscopic colorectal surgery · 1 site · Universitaire Ziekenhuizen KU Leuven
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Robotic colorectal surgery (a procedure) and Laparoscopic colorectal surgery (a procedure). Condition(s) listed: IBD - Inflammatory Bowel Disease.
Participants are assigned to groups by chance (randomized).
It is single-blind: participants do not know which group they are in.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
- At least 18 years of age at the time of signing the Informed Consent Form (ICF)
- Diagnosed with IBD and eligible for elective minimally invasive colorectal surgery, including:
Plus 3 more requirement(s). There are also 4 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 110 participants are expected to take part.
- Start date: 2025-10-01.
- Main results expected around 2028-05-01 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Belgium.
Main thing being measured
- Postoperative morbidity (During the first 90 days postoperatively)
In the researchers’ words
The aim of this study is to better understand whether robotic surgery leads to better outcomes than laparoscopy in terms of complications, recovery and quality of life.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | IBD - Inflammatory Bowel Disease |
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven |
| Enrollment | 110 (estimated) |
| Start date | 2025-10-01 |
| Primary completion (est.) | 2028-05-01 |
| First posted | 2025-11-17 |
| Last updated | 2025-11-17 |
| Official title | A Controlled Randomized Trial Comparing Multiport RObotic and Laparoscopic Surgery for Elective Colorectal Resections in IBD Patients |
| ClinicalTrials.gov ID | NCT07230262 |
Interventions
- Robotic colorectal surgery (Procedure)
Colorectal surgery using robotic procedure - Laparoscopic colorectal surgery (Procedure)
Colorectal surgery using laparoscopic procedure
Full eligibility criteria (from the record)
Inclusion Criteria: 1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures 2. At least 18 years of age at the time of signing the Informed Consent Form (ICF) 3. Diagnosed with IBD and eligible for elective minimally invasive colorectal surgery, including: 1.4 Ileocecal/ileocolic resections 1.5 Segmental colectomies 1.6 Total colectomy 1.7 Proctocolectomy 1.8 Proctectomy 4. Procedures involving primary anastomosis or temporary or permanent stoma creation 5. Suitable for minimally invasive surgery Exclusion Criteria: 1. Non IBD patients 2. Urgent surgery (<24 hours from hospital admission) 3. Not suitable for minimally invasive surgery 4. Ileoanal pouch construction
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Abdominal Surgery | Leuven, Vlaams Brabant | Belgium | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.